• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Prenatal exposure to components of fine particulate matter is associated with increased risk of autism spectrum disorder

byJayden BerdugoandSimon Pan
January 13, 2026
in Chronic Disease, Obstetrics, Pediatrics, Psychiatry, Public Health
Reading Time: 4 mins read
0
Share on FacebookShare on Twitter

1. In this cohort of singleton births in Ontario, prenatal exposure to specific components of Fine particulate matter (PM2.5), specifically sulfate (SO42-) and ammonium (NH4+), was associated with an increased autism spectrum disorder (ASD) risk, while overall PM2.5 was not.

2. The greatest risk occurred during the second and third trimesters for PM2.5 components, and the first year of life for ozone (O3).

Evidence Rating Level: 2 (Good) 

Study Rundown: Fine particulate matter (PM2.5) is a known pollutant associated with many health issues and remains a large public health concern. Fetal exposure to these toxins in pre-natal or early post-natal periods has been associated with neurodevelopmental conditions such as autism spectrum disorder (ASD), potentially through mechanisms such as inflammation, oxidative stress, and epigenetic changes. However, most previous studies have investigated PM2.5 as a whole, overlooking the distinct aspects of its chemical composition that may have varying effects. To address these gaps, this retrospective cohort study examined the associations between prenatal and early postnatal exposure to PM2.5 components, nitrogen dioxide (NO2), and ozone (O3) and the risk of ASD diagnosis. 

Concentrations of PM2.5 components, such as black carbon, dust, and ammonium, were assigned biweekly, while NO2 and O3 were assigned weekly from conception to 36 weeks of age. Follow-up took place from birth until age 5 years or ASD diagnosis, if that occurred sooner. Prenatal exposure to PM2.5 was only significantly associated with ASD when not accounting for the specific components. Among PM2.5 components, NH4+ was consistently associated with ASD risk across adjusted models. Several limitations exist, including decreased generalizability due to differences in socioeconomic status and excluding individuals without OHIP coverage. Despite the limitations, this study provided new evidence that PM2.5 components were associated with increased ASD risk, highlighting the importance of implementing public health strategies to reduce harmful air pollution. 

Click here to read the study in JAMA Network Open 

RELATED REPORTS

Metformin is associated with lowering maternal hyperglycemia and reducing the risk of neonatal hypoglycemia among pregnant patients at risk of preterm delivery

Baseline cannabis use may not be associated with abstinence from vaping

Middle-aged and older Canadians at high risk of obstructive sleep apnea may have worse mental health outcomes

Relevant Reading: Association between exposure to ambient particulate matters and risks of autism spectrum disorder in children: a systematic review and exposure-response meta-analysis

In-Depth [retrospective cohort study]: This population-based retrospective cohort study was designed to assess if exposure to environmental pollutants ASD diagnosis are associated. A total of 2,183,324 singleton live births were included (mean [SD] maternal age at delivery 30.5 [5.4], mean [SD] gestational age at birth, 39.2 [1.1] weeks). During the first year of life, there was a significant association between prenatal PM2.5 exposure and increased risk of ASD (HR, 1.15; 95% CI, 1.07-1.23; per 1-IQR increase, 3.5 μg/m3 increase). However, after adjusting for NH4+ and SO42- during their critical periods, the association was no longer significant. Prenatal exposure to NH4+ was associated with an elevated risk of ASD in PM2.5 residual variation-adjusted (HR, 1.13; 95% CI, 1.05-1.23, per 1-IQR [0.60 μg/m3]) and postnatal exposure models (HR, 1.12; 95% CI, 1.01-1.23). O3 exposure was initially associated with increased ASD risk (HR, 1.10; 95% CI, 1.06-1.15; per 1-IQR [19.14 ppb]) in PM2.5 adjusted models; however, this association weakened after adjusting for first year exposure. Among exposure periods, only the first year of O3 exposure demonstrated a significant association with ASD. In summary, prenatal exposure to specific components of PM2.5 (NH4+ and SO42-), and postnatal O3 were associated with increased risk of ASD. 

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

Tags: ammoniumautism spectrum disorderfine particulate matterobstetricsozonepediatricsprenatal exposurepsychiatrysulfate
Previous Post

Center of Disease Control layoffs raise alarm over surveillance and preparedness

Next Post

Longer bouts of exercise may be associated with decreased mortality and cardiovascular disease

RelatedReports

Prenatal antidepressant exposure may increase risk of poor motor development
Chronic Disease

Metformin is associated with lowering maternal hyperglycemia and reducing the risk of neonatal hypoglycemia among pregnant patients at risk of preterm delivery

January 13, 2026
Systematic review examines benefits and adverse effects of cannabinoid therapy
Chronic Disease

Baseline cannabis use may not be associated with abstinence from vaping

January 13, 2026
Admission may not be needed following sleep apnea surgery
Chronic Disease

Middle-aged and older Canadians at high risk of obstructive sleep apnea may have worse mental health outcomes

January 12, 2026
Admission may not be needed following sleep apnea surgery
Weekly Rewinds

2 Minute Medicine Rewind December 29th, 2025

January 12, 2026
Next Post
Home-based walking program an effective treatment for peripheral artery disease

Longer bouts of exercise may be associated with decreased mortality and cardiovascular disease

FDA-approved weight loss medications associated with weight loss at one year

Mediterranean diet may be effective for managing IBS

Traumatic spinal cord injury rates remain stable in the United States

Increased gut inflammation is associated with greater structural spinal damage in axial spondyloarthritis

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Edaravone dexborneol improves functional independence in patients with acute ischaemic stroke following endovascular thrombectomy
  • Yartemlea (narsoplimab-wuug) improves platelets hemolysis organ function hematopoietic stem cell transplant–associated thrombotic microangiopathy transplant patients
  • FDA highlights flexible chemistry manufacturing controls expectations for cell and gene therapies
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.